| Courtney Lashon Sublett, RN | |
|
501 Riverchase Blvd, Madison, TN 37115-2035 | |
| (757) 373-7079 | |
| Not Available |
| Full Name | Courtney Lashon Sublett |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 501 Riverchase Blvd, Madison, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386310209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0001265487 (Virginia) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 0001265487 (Virginia) | Primary |
| Entity Name | Ambulatory Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720192230 PECOS PAC ID: 2264320829 Enrollment ID: O20220215002595 |
News Archive
The New York Times reports on Medicaid pooled trusts: "[T]here is a little-known way for some people in certain states to receive home care through Medicaid, without requiring them to impoverish themselves first. Here's how it works: a federal law established in 1993 allows disabled people to put their monthly income or assets — above the amounts Medicaid allows them to keep — into a special type of pooled trust.
With the American Cancer Society estimating 1.76 million new cases and more than 600,000 deaths during 2019 in the U.S. alone, cancer remains a critical healthcare challenge.
The Wall Street Journal: Senate Majority Leader Harry Reid today said he plans to move the " first part of a job-creation package next week." In discussing the measure during a Capitol Hill press conference, Democratic leaders were short of specifics "but pledged to make the issue of job creation their top priority in 2010."
The discovery of the cell, which they are calling 'the cell of origin' sheds new light on what fuels cancer growth and how to potentially stop it.
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
› Verified 5 days ago
| Entity Name | Northstar Anesthesia Of Virginia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194488791 PECOS PAC ID: 6608268826 Enrollment ID: O20221205003063 |
News Archive
The New York Times reports on Medicaid pooled trusts: "[T]here is a little-known way for some people in certain states to receive home care through Medicaid, without requiring them to impoverish themselves first. Here's how it works: a federal law established in 1993 allows disabled people to put their monthly income or assets — above the amounts Medicaid allows them to keep — into a special type of pooled trust.
With the American Cancer Society estimating 1.76 million new cases and more than 600,000 deaths during 2019 in the U.S. alone, cancer remains a critical healthcare challenge.
The Wall Street Journal: Senate Majority Leader Harry Reid today said he plans to move the " first part of a job-creation package next week." In discussing the measure during a Capitol Hill press conference, Democratic leaders were short of specifics "but pledged to make the issue of job creation their top priority in 2010."
The discovery of the cell, which they are calling 'the cell of origin' sheds new light on what fuels cancer growth and how to potentially stop it.
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Courtney Lashon Sublett, RN 501 Riverchase Blvd, Madison, TN 37115-2035 Ph: (757) 373-7079 | Courtney Lashon Sublett, RN 501 Riverchase Blvd, Madison, TN 37115-2035 Ph: (757) 373-7079 |
News Archive
The New York Times reports on Medicaid pooled trusts: "[T]here is a little-known way for some people in certain states to receive home care through Medicaid, without requiring them to impoverish themselves first. Here's how it works: a federal law established in 1993 allows disabled people to put their monthly income or assets — above the amounts Medicaid allows them to keep — into a special type of pooled trust.
With the American Cancer Society estimating 1.76 million new cases and more than 600,000 deaths during 2019 in the U.S. alone, cancer remains a critical healthcare challenge.
The Wall Street Journal: Senate Majority Leader Harry Reid today said he plans to move the " first part of a job-creation package next week." In discussing the measure during a Capitol Hill press conference, Democratic leaders were short of specifics "but pledged to make the issue of job creation their top priority in 2010."
The discovery of the cell, which they are calling 'the cell of origin' sheds new light on what fuels cancer growth and how to potentially stop it.
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
› Verified 5 days ago